Histiocytic Sarcoma
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders (NCT04079179) | Carl Allen | 2021-04-19 |
| Pembrolizumab in Neoplasms or Lymphomas (NCT03316573) | Dana-Farber Cancer Institute | 2017-12-07 |
| Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) (NCT03155620) | National Cancer Institute (NCI) | 2017-07-31 |
| Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall (NCT03651375) | Maria Sklodowska-Curie National Research Institute of Oncology | 2017-02-11 |
Track Histiocytic Sarcoma automatically
Every clearance here is in the API, with alerts when new ones post.